Brandon explains:
"We’re in an exciting time in the digital therapeutics space, because it’s early days in the industry for measuring the results of behavior programs and having clinical evidence at a level that’s on par with medical devices and pharmaceutical solutions." — Brandon Masterson, 2Morrow, Inc.
